Cargando…
First clinical study of germline-targeting strategy: One step closer to a successful bnAb-based HIV vaccine
Autores principales: | Sun, Caijun, Zuo, Teng, Wen, Ziyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898727/ https://www.ncbi.nlm.nih.gov/pubmed/36747593 http://dx.doi.org/10.1016/j.xinn.2023.100374 |
Ejemplares similares
-
To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1
por: Griffith, Sarah A., et al.
Publicado: (2021) -
Understanding the Determinants of BnAb Induction in Acute HCV Infection
por: Underwood, Alexander P., et al.
Publicado: (2018) -
Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs
por: Seaman, Michael S., et al.
Publicado: (2020) -
Introduction of the YTE mutation into the non-immunogenic HIV bnAb
PGT121 induces anti-drug antibodies in macaques
por: Rosenberg, Yvonne J., et al.
Publicado: (2019) -
Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in Botswana
por: Moraka, Natasha Onalenna, et al.
Publicado: (2023)